BioCentury
ARTICLE | Clinical News

ProAir HFA albuterol regulatory update

March 12, 2012 7:00 AM UTC

FDA approved a dose counter for use with Teva's ProAir HFA albuterol sulfate inhalation aerosol to treat or prevent bronchospasm with reversible obstructive airway disease and to prevent exercise-indu...